NovaBridge Biosciences Equity Method Investment, Other than Temporary Impairment
NovaBridge Biosciences (NBP) reported Equity Method Investment, Other than Temporary Impairment of CNY 0 for the 12-month period ending 2023-12-31, per its 20-F filed 2024-04-30.
Financial Statements › Income Statement › Other Income
us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment · last filed 2026-04-07
CNY
| Period end | Equity Method Investment, Other than Temporary Impairment 6 month | Equity Method Investment, Other than Temporary Impairment 12 month |
|---|---|---|
| 2023-12-31 | 0.00 CNY 20-F · filed 2024-04-30 | |
| 2022-12-31 | 0.00 CNY 20-F · filed 2024-04-30 | |
| 2022-06-30 | 0.00 CNY 6-K · filed 2022-11-10 | |
| 2021-12-31 | 0.00 CNY 20-F · filed 2024-04-30 | |
| 2020-12-31 | 0.00 CNY 20-F · filed 2023-05-01 |
USD
| Period end | Equity Method Investment, Other than Temporary Impairment 12 month |
|---|---|
| 2023-12-31 | $0.00 20-F · filed 2026-04-07 |
| 2022-12-31 | $0.00 20-F · filed 2025-04-03 |